arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BeyondSpring Inc.

BYSI
$0.88 ▼ -0.01 (-0.97%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
19 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $36.2M
Dividend Yield
Revenue Growth
Op. Margin
ROIC 7.0%
FCF / Share $-0.08
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-2.16M
↓ -1.0%
FCF / Share Free cash flow per share
$-0.08
↑ +24.4%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Returns
50
Cash Quality
99

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 19 quarters